
Bruker Corporation BRKR
$ 54.23
-1.72%
Quarterly report 2026-Q1
added 05-07-2026
Bruker Corporation Interest Expense 2011-2026 | BRKR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Bruker Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -46.2 M | -38.2 M | 16.4 M | 16.1 M | 14.3 M | 14.4 M | 16 M | 12.6 M | 15.4 M | 13.2 M | 13 M | 13.3 M | 13.4 M | 14.3 M | 7.3 M | 5.6 M | 7.5 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.4 M | -46.2 M | 6.38 M |
Quarterly Interest Expense Bruker Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.7 M | -20 M | -11.4 M | -6.7 M | - | -12.8 M | 15.7 M | 6.8 M | - | 3.9 M | 3.9 M | 4.2 M | - | 3.7 M | -4 M | 4.1 M | - | - | - | - | - | - | - | - | - | - | -100 K | -500 K | - | 100 K | -100 K | 600 K | - | 800 K | 2.4 M | - | - | 500 K | -400 K | -200 K | - | 500 K | - | - | - | 3.2 M | 3.1 M | 3 M | - | 3.2 M | 3.1 M | 3.1 M | - | 3.4 M | 3.5 M | 3.3 M | - | 1.7 M | 1.6 M | 1.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15.7 M | -20 M | 1.01 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | - | - | $ 162 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
624 K | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 13.44 | -2.89 % | $ 381 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 8.28 | 1.85 % | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.54 | 1.99 % | $ 34 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 79.39 | -0.69 % | $ 4.33 B | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.37 | -3.52 % | $ 55.7 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.82 | -0.06 % | $ 418 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 11.72 | -0.38 % | $ 420 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
LENSAR
LNSR
|
636 K | $ 5.82 | - | $ 69.6 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
455 K | $ 37.14 | -1.25 % | $ 314 M | ||
|
MiMedx Group
MDXG
|
-558 K | $ 3.6 | -2.44 % | $ 532 M | ||
|
Butterfly Network
BFLY
|
2.77 M | $ 5.54 | -2.46 % | $ 1.37 B | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
-668 K | $ 1.15 | -16.06 % | $ 48.1 M | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 9.31 | 0.87 % | $ 369 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 80.39 | -0.16 % | $ 10.9 B | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 149.7 | 0.34 % | $ 10.5 B | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 6.63 | -0.38 % | $ 200 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 34.77 | 1.05 % | $ 1.08 B | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 42.7 | 0.61 % | $ 1.25 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 90.98 | -1.22 % | $ 3.16 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
TransMedics Group
TMDX
|
3.87 M | $ 72.91 | -0.92 % | $ 2.48 B | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 85.11 | -0.76 % | $ 49.8 B |